Fairview Capital Investment Management’s Elevance Health ELV Stock Holding History

Fairview Capital Investment Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,847	Closed	-$530K	–	146
2019 Q1	$530K	Hold	1,847	–	–	0.03%	107
2018 Q4	$485K	Hold	1,847	–	–	0.03%	103
2018 Q3	$506K	Buy	1,847 +58	+3%	+$15.1K	0.03%	90
2018 Q2	$426K	Buy	1,789 +29	+2%	+$6.72K	0.02%	97
2018 Q1	$386K	Hold	1,760	–	–	0.02%	95
2017 Q4	$396K	Hold	1,760	–	–	0.02%	90
2017 Q3	$334K	Hold	1,760	–	–	0.02%	93
2017 Q2	$331K	Hold	1,760	–	–	0.02%	90
2017 Q1	$291K	Hold	1,760	–	–	0.02%	79
2016 Q4	$253K	Hold	1,760	–	–	0.02%	78
2016 Q3	$221K	Hold	1,760	–	–	0.02%	79
2016 Q2	$231K	Hold	1,760	–	–	0.02%	69
2016 Q1	$245K	Buy	+1,760	New	+$235K	0.02%	68

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Fairview Capital Investment Management's ELV Position: Q2 2019 in Review

Fairview Capital Investment Management sold out of Elevance Health (ELV) in Q2 2019, closing a stake of 1,847 shares — an estimated $530K sold.

Fairview Capital Investment Management first reported a position in ELV in Q1 2016 and held it in 13 quarters. The position peaked at $530K in Q1 2019. 1,030 funds tracked by Wall St. Rank hold ELV as of Q2 2019.

Fairview Capital Investment Management reported no remaining Elevance Health position as of Q2 2019 after selling out during the quarter.
Fairview Capital Investment Management sold 1,847 Elevance Health shares in Q2 2019, an estimated $530K.
Fairview Capital Investment Management first reported a position in Elevance Health in Q1 2016 and held it in 13 quarters.
Fairview Capital Investment Management's Elevance Health position peaked at $530K in Q1 2019.
1,030 funds tracked by Wall St. Rank held Elevance Health as of Q2 2019.

Based on Fairview Capital Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.